sigmaplot v13 statistical programme (SYSTAT)
SYSTAT is a verified supplier 
90
Structured Review
SYSTAT
sigmaplot v13 statistical programme
Sigmaplot V13 Statistical Programme, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigmaplot+v13+statistical+programme/sigmaplot+software/pm30939113-55-7-11
Average 90 stars, based on 1 article reviews
Sigmaplot V13 Statistical Programme, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigmaplot+v13+statistical+programme/sigmaplot+software/pm30939113-55-7-11
Average 90 stars, based on 1 article reviews
sigmaplot v13 statistical programme - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Comparison of the sulfur-oxygenation of cysteine and S-carboxymethyl-l-cysteine in human hepatic cytosol and the rôle of cysteine dioxygenase. Article Snippet: Objectives To determine the Km, Vmax, cofactor, activator and inhibitor requirements of human cysteine dioxygenase and S-carboxymethyl-L-cysteine S-oxygenase with respect to both L-Cysteine and S-carboxymethyl-L-cysteine as substrates.. Methods In vitro human hepatic cytosolic fraction enzyme assays were optimised for cysteine dioxygenase activity using L-Cysteine as substrate and the effect of various cofactors, activators and inhibitors on the S-oxidations of both L-Cysteine and S-carboxymethyl-L-cysteine were investigated.. Key findings The results of the in vitro reaction phenotyping investigation found that although both cysteine dioxygenase and S-carboxymethyl-L-cysteine S-oxygenase required Fe for catalytic activity both enzymes showed considerable divergence in cofactor, activator and inhibitor specificities. Article Title: The S-oxidation of S-carboxymethyl-L-cysteine in hepatic cytosolic fractions from BTBR and phenylketonuria enu1 and enu2 mice. Article Snippet: Referee 2 comments 1.. The abstract appears to be missing) 1.. Mice that were heterozygous dominant for the enu1 and enu2 mutation in PAH resulted in hepatic PAH assays for SCMC that had significantly increased calculated Km (wt/enu1, 1.84-2.12 fold increase and wt/enu2 a 2.75 fold increase in PAH assays). Article Title: Drug S-oxidation and phenylalanine hydroxylase: a biomarker for neurodegenerative susceptibility in Parkinson's disease and amyotrophic lateral sclerosis. Article Snippet: Background: The S-oxidation of S-carboxymethyl-L-cysteine has been reported previously to be a biomarker of disease susceptibility in Parkinson’s disease and amyotrophic lateral sclerosis.. In the present investigation, the original observations have been extended and confirmed.. Methods: Meta-analysis of previously published investigations into the S-oxidation polymorphism together with new subject data was evaluated. |